Does DARATUMUMAB Cause Progressive multifocal leukoencephalopathy? 108 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 108 reports of Progressive multifocal leukoencephalopathy have been filed in association with DARATUMUMAB (DARZALEX). This represents 0.4% of all adverse event reports for DARATUMUMAB.
108
Reports of Progressive multifocal leukoencephalopathy with DARATUMUMAB
0.4%
of all DARATUMUMAB reports
34
Deaths
45
Hospitalizations
How Dangerous Is Progressive multifocal leukoencephalopathy From DARATUMUMAB?
Of the 108 reports, 34 (31.5%) resulted in death, 45 (41.7%) required hospitalization, and 15 (13.9%) were considered life-threatening.
Is Progressive multifocal leukoencephalopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DARATUMUMAB. However, 108 reports have been filed with the FAERS database.
What Other Side Effects Does DARATUMUMAB Cause?
Plasma cell myeloma (2,980)
Infusion related reaction (2,557)
Off label use (2,494)
Pneumonia (1,450)
Neutropenia (1,351)
Drug ineffective (1,110)
Thrombocytopenia (1,089)
Death (1,088)
Pyrexia (1,032)
Dyspnoea (996)
What Other Drugs Cause Progressive multifocal leukoencephalopathy?
NATALIZUMAB (1,668)
RITUXIMAB (1,647)
CYCLOPHOSPHAMIDE (782)
PREDNISONE (606)
PREDNISOLONE (439)
TACROLIMUS (438)
METHOTREXATE (428)
DOXORUBICIN (421)
MYCOPHENOLATE MOFETIL (414)
VINCRISTINE (376)
Which DARATUMUMAB Alternatives Have Lower Progressive multifocal leukoencephalopathy Risk?
DARATUMUMAB vs DARATUMUMAB\HYALURONIDASE-FIHJ
DARATUMUMAB vs DARBEPOETIN ALFA
DARATUMUMAB vs DARIDOREXANT
DARATUMUMAB vs DARIFENACIN HYDROBROMIDE
DARATUMUMAB vs DAROLUTAMIDE